MedTrace Logo

Prevention of Post Herpetic Neuralgia by Ultrasound Guided Single Nerve Block in the ED

NCT04530162 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-06-16

No results posted yet for this study

Summary

Herpes zoster causes significant morbidity on over 1 million Americans every year. Although the majority of herpes zoster pain will self-resolve within one week, a significant proportion of patients will develop postherpetic neuralgia (PHN), which is characterized by debilitating pain that persists more than three months after the initial symptoms. Nerve blocks have been previously studied as a method to control herpes zoster pain in outpatient pain clinics and inpatient settings. This study aims to investigate whether emergency department ultrasound guided nerve blocks can prevent PHN and effectively treat acute herpes zoster pain.

Conditions

Interventions

PROCEDURE

Ultrasound guided nerve block

nerve block using bupivacaine and dexamethasone.

Sponsors & Collaborators

  • Antonios Likourezos

    lead OTHER

Principal Investigators

  • Leily Naraghi, MD · Maimonides Medical Center

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-06-10
Completion
2022-06-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04530162 on ClinicalTrials.gov